Loading clinical trials...
Loading clinical trials...
There are very little data on human papillomavirus (HPV) vaccination among the 18 million women living with HIV (WLWH) globally, who constitute a population most vulnerable to HPV and the resultant ce...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of British Columbia
NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more
NCT06532279 · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, and more
NCT05639972 · HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, and more
NCT07044297 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
NCT07377656 · HPV Vaccine
Positive Health Services - Fraser Health
Surrey, British Columbia
University of British Columbia
Vancouver, British Columbia
Health Sciences Centre
Winnipeg, Manitoba
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions